igeahub.com
AbbVie Agrees to Buy Stemcentrx - IgeaHub
April 28, 2016 Pharmaceutical company AbbVie Inc. has agreed to acquire Stemcentrx Inc., a cancer-drug developer, for $5.8 billion. This is part of